Skip to main content

Advertisement

Log in

Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis

  • Short Communication
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary.

To clarify the mechanism of brain and spinal cord impairment in amyotrophic lateral sclerosis (ALS), we measured the cerebrospinal fluid (CSF) levels of substance P (SP) in 11 patients with sporadic ALS. Findings were compared with those obtained in controls and diseased controls. The CSF SP levels of patients with ALS, and particularly in patients with a disease duration of less than 2.5 years, were significantly higher than those in controls.

These findings strongly suggested that SP may play an important role in the pathophysiology of ALS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received January 30, 1999; accepted June 15, 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsuishi, T., Nagamitsu, S., Shoji, H. et al. Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis. J Neural Transm 106, 943–948 (1999). https://doi.org/10.1007/s007020050214

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s007020050214

Navigation